The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
maybe it doesn't matter in other words maybe and even the keys paper doesn't tell us that metformin wouldn't be beneficial because it could be that those people if they were on nothing as their matched cohorts were on nothing would have been dying at you know a hazard ratio of three and this brought it down to 1.5 in which case you would say there is some zero protection there it is putting the brakes on this process
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if you don't censor meaning if you include everybody including when people on Metformin with diabetes die if you censor them it comes down to 1.39